by Carolyn Haywood | Aug 1, 2020 | US & International
Background Supplementary Protection Certificates (SPCs) are available under EU law to effectively compensate patent owners for some of the lost patent protection that inevitability occurs due to the time it takes to obtain marketing authorisation. Article 3 of the SPC...
by Alex Bajjon | Jul 1, 2020 | Briefings, UK
Background Regeneron owned two patents relating to transgenic mice that produce hybrid antibodies containing human variable regions and mouse constant regions. More specifically, the claimed mice contain an in situ replacement at a murine chromosomal immunoglobulin...
by David Eyre | Jun 1, 2020 | Briefings, US & International
Earlier this year we reported that the European Patent Office (EPO) has stated that the requirements for being an inventor can only be fulfilled by a natural person. The United States Patent and Trademark Office (USPTO) has now considered the parallel subject matter...
by Alex Bajjon | May 1, 2020 | Briefings, US & International
Background This case is a preliminary ruling from the Courts of Justice of the European Union (CJEU) following a referral from the German Federal Patent Court regarding Supplementary Protection Certificates. In particular, the referral relates to Article 3(a) of EU...
by Alex Bajjon | Apr 1, 2020 | Briefings, US & International
Genentech owns US Patents 7,846,441 and 7,892,549 which both relate to treating cancers characterised by overexpression of the ErbB2 receptor (which includes breast cancers). The claims of these two patents relate to treating a human patient with a combination of an...
Recent Comments